This site is intended for Healthcare Professionals only

Auden Mckenzie

sharing-1280x720

CAT upholds £2.8m fine for Accord and Auden Mckenzie for illegal market sharing

Accord-UK and Auden Mckenzie have lost their appeal to the Competition Appeal Tribunal to overturn a £2.8 million fine for illegal market sharing relating to hydrocortisone 20mg tablets.

30 Apr 2024 , 1 Min Article

appeal-1280x720

Suppliers face £130m fine after appeal against CMA finding on hydrocortisone pricing fails

Auden McKenzie and Actavis UK, which raised prices for hydrocortisone tablets by over 10,000 per cent over a decade, have had their appeal against a Competition and Markets Authority finding of excessive pricing rejected.

19 Sep 2023 , 1 Min Article

tablet medicine drug summary.jpg

Drug companies fined £260m for hydrocortisone price fixing

Drug companies fined £260m for "excessive and unfair" price hikes to hydrocortisone tablets over a 10 year period.

15 Jul 2021 , 1 Min Article

medicine-tablet-summary.jpg

Pharma director disqualified for breaking competition law

A director of a pharmaceutical manufacturer has been barred from holding a directorship at any UK company after admitting to his role in two separate anticompetitive agreements.

04 Jun 2020 , 1 Min Article

drug-tablet-pill-medicine-CMA-collusion-summary.jpg

Four companies fined £3.4m in CMA nortriptyline probe

Wholesaler Lexon (UK) has been fined although it denies any infringement.

04 Mar 2020 , 1 Min Article

Change privacy settings